Thomas G. Pharma SRL
Thomas G. Pharma reported total assets of 741,173 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of Thomas G. Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Thomas G. Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 15 Aug 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
Thomas G. Pharma's financial analysis
- Solvency46.9%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Thomas G. Pharma
Thomas G. Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0699.921.217
- VAT number
- BE0699921217
- Peppol
- Registered · 0208:0699921217 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jul 2018
- Registered office
- 1420 Braine-l'Alleud
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Thomas G. Pharma (SRL) has been based in Braine-l'Alleud since 2018, active in: activities of holding companies. For 2025, it reports a net profit of 45,665 € and equity of 347,740 €; its revenue is not published. Its solvency stands at 46.9%, below the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Thomas G. Pharma
Companies in the same business, of comparable size and area, outside its group.
- Vuegen TS Activities of holding companies Tessenderlo-Ham · balance sheet 740,963 €
- Van Steijn Beheer Activities of holding companies Hoogstraten · balance sheet 740,900 €
- Sadok Activities of holding companies Tielt · balance sheet 741,791 €
- Seasite Activities of holding companies Knokke-Heist · balance sheet 741,799 €
- Pelbo Invest Activities of holding companies Herselt · balance sheet 740,533 €
- DHG Holding Activities of holding companies Genk · balance sheet 740,440 €
- LD Farma Activities of holding companies Linter · balance sheet 741,960 €
- Immo STPP Activities of holding companies Genk · balance sheet 741,966 €
Frequently asked questions about Thomas G. Pharma
What is the revenue of Thomas G. Pharma?
Thomas G. Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Thomas G. Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0699921217 for Thomas G. Pharma, if the company is VAT-registered. Its company number (CBE) is 0699.921.217.
Where is the registered office of Thomas G. Pharma?
According to the CBE register, the registered office of Thomas G. Pharma is in 1420 Braine-l'Alleud.
What is the equity of Thomas G. Pharma?
At the close of the 2025 financial year, the equity of Thomas G. Pharma amounts to 347,740 €, a solvency of 46.9% of total assets.
Who manages Thomas G. Pharma?
The register lists 1 active mandates at Thomas G. Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Thomas G. Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →